Welcome to Cancer Gene Therapy

Cancer Gene Therapy is the essential gene therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene therapy for cancer. It publishes original laboratory and clinical research papers, case reports and review articles on topics including RNAi approaches, drug resistance, hematopoietic gene transfer, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors,translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair.

*** Announcing Cancer Gene Therapy Open ***

Cancer Gene Therapy now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from the press release or our FAQs page.

******

Now live: Cell Death & Disease

Cell Death & Disease is the online sister journal to Cell Death & Differentiation and makes all content freely available to researchers worldwide. Brought to you by the high-impact editorial team of Cell Death & Differentiation, Cell Death & Disease is a peer-reviewed open-access online journal in the field of translational cell death. The journal seeks to promote diverse and integrated areas of Experimental and Internal Medicine with its specialties, including Cancer, Immunity and Neuroscience.

Welcome to Cell Research

Cell Research has a broad scope in basic molecular and cell biology research, including cell growth and differentiation, signal transduction, apoptosis, stem cells, development, immunology, neurosciences, plant cell biology, chromatin modulation, epigenetics and transcription. Cell Research is China's leading journal in the life sciences.